Inspired by high technology and modern European design, the Titanflex styles are super flexible at the bridge and temple and ultra lightweight. In contrast to the traditional memory bridge with “chucking pipe” solder joints, these frames use a flat metal bridge. Adjustability is a brand hallmark, as well as an easy temple shorting system, for a perfect fit frame. Debuts in February. http://www.tura.com/
Vuarnet offers New Glacier Sunglasses
Vuarnet now offers its famous Glacier sunglasses in two new colours: full white and full blue. The aviator-style frame combines an ultra-light metal with Mazzucchelli acetate, and is available with Skilynx mineral lenses or new Polarlynx polarizing lenses. This frame was first launched in 1957. http://www.vuarnet.us/
New Canadian Distributor Announced for Rodenstock Frame Lines
Rodenstock continued with its reorganization in Canada, announcing that the Rodenstock line of frames will now be distributed exclusively through Eyestock.ca. The new distributor for frames is owned and operated by Jeremy Carvalho, formerly the Managing Director of Rodenstock Canada. Carvalho is putting emphasis on providing high tech and high touch service, citing a user-friendly website and a knowledgeable sales team. Other frame lines, including Rocco, Claudia Schiffer and Mercedes Benz will also be made available through the eyestock.ca website.
Reorganization of Rodenstock’s lens business, through the appointment of Plastic Plus as exclusive Canadian lens distributor, was made earlier this month.
For more information, click HERE.
Actavis Aquisition of Allergan Set to Proceed Early
The U.S. Federal Trade Commission has granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act for Actavis’ pending acquisition of Allergan. The close of business record date has been set for January 22, 2015 for shareholder meetings.
The two companies combined will create one of the top 10 global growth pharmaceuticals with expected revenue of $23 billion in 2015.
Read the full press release here: http://agn.client.shareholder.com/releaseDetail.cfm?ReleaseID=890722
Carl Zeiss Meditech Posts Slight Revenue Gain, Increases R&D
Carl Zeiss Meditech, the surgical equipment and solutions group affiliated with Carl Zeiss AG, posted a modest 3% revenue gain in the financial year ending 2014, notwithstanding unfavourable currency affects and competitive pressures.
Total sales reached $1.278 billion CND, a slight increase from the $1.275 billion in the prior year. Profits before taxes were up 13.3%. Sales of the ophthalmic division declined 4.6% to $524 million CDN, due to strong competitiveness in the diagnostic equipment industry.
Overall Research and Development expenditures reached 11% of revenue, the highest level in three years. The group plans to make even further increases in R&D spending targeted in the ophthalmic surgical business even at the expense of short-term profitability.
The Americas region is the only one to have experienced a decline, with a drop in revenue of 9.4%, about 1/3 of which was due to currency changes.
Carl Zeiss Meditech has nearly 3,000 world-wide employees and is 65% held by Carl Zeiss AG, one of the world’s leading optical and optoelectronic corporations.
For more information: http://www.zeiss.com/content/dam/Meditec/downloads/pdf/press-releases/czm_2014_qiv_en.pdf